This 3D animation has been created for the U.S. product launch of Abstral(R) (fentanyl) Sublingual Tablets, the treatment for Breakthrough Cancer Pain (BTcP). We began the video with the introduction of the cause of pain; highlighting metastatic bone cancer, before showcasing the mechanism of action (MOA) of the drug and its significant effect on breakthrough cancer pain.
(1) Breakthrough cancer pain is defined as a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain. Breakthrough cancer pain occurs in the majority of patients who are already receiving chronic, long-acting opioid pain management and yet have episodes of severe tumor- and treatment-related cancer pain.
reference: (1) www.galenabiopharma.com